Moderna to request US and Europe authorisation of its covid-19 vaccine
A US Cambridge, Massachusetts based Moderna just released a media press with which to announce the primary efficacy analysis in the Phase 3 COVE…
View Opportunity
A US Cambridge, Massachusetts based Moderna just released a media press with which to announce the primary efficacy analysis in the Phase 3 COVE…
View Opportunity